867034-10-4 Usage
Uses
Used in Pharmaceutical Research and Development:
Ethyl 7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate serves as a crucial intermediate in the synthesis of complex organic compounds, playing a significant role in the development of new pharmaceuticals. Its unique structure and functional groups make it a valuable building block for creating novel drug candidates with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, ethyl 7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate is utilized as a versatile intermediate for constructing a variety of chemical entities. Its reactivity and polarity allow for the formation of diverse molecular structures, expanding the scope of synthetic chemistry and enabling the creation of new compounds with unique properties and potential applications.
Used in Chemical Research:
Ethyl 7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate is also employed in chemical research to study the properties and reactivity of pyrrolopyridine-based compounds. Its unique structure provides insights into the behavior of fused ring systems and the influence of substituents on the molecule's properties, contributing to the advancement of chemical knowledge and the discovery of new synthetic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 867034-10-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,0,3 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 867034-10:
(8*8)+(7*6)+(6*7)+(5*0)+(4*3)+(3*4)+(2*1)+(1*0)=174
174 % 10 = 4
So 867034-10-4 is a valid CAS Registry Number.
867034-10-4Relevant academic research and scientific papers
HETEROCYCLIC PAD4 INHIBITORS
-
Page/Page column 179, (2021/08/20)
The disclosure generally relates to substituted heterocyclic compounds of Formula (Ia), which are inhibitors of PAD4, method for preparing these compounds, pharmaceutical compositions comprising these compounds and use of these compounds in the treatment of a disease or a disorder associated with PAD4 enzyme activity.
6-AZAINDOLE COMPOUND
-
, (2008/06/13)
A compound represented by the formula (I) wherein R1, R2, R3 and R6 are the same or different and each is a hydrogen atom or a substituent; one of R4 and R5 is a hydrogen atom and the other is a group represented by the formula: -C(=X)-R7 wherein X is N-O-R8 or N-NH-R9 wherein R8 and R9 are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7 is a hydrogen atom or a substituent, and the like and a salt thereof have a superior IκB kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
